Sutton Wealth Advisors’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-5
Closed -$1.06K 1248
2022
Q4
$1.06K Hold
5
﹤0.01% 1306
2022
Q3
$786 Hold
5
﹤0.01% 1359
2022
Q2
$748 Buy
+5
New +$724 ﹤0.01% 1362
2022
Q1
Sell
-3
Closed -$653 1678
2021
Q4
$653 Buy
+3
New +$628 ﹤0.01% 1443
2020
Q3
Sell
-475
Closed -$44.2K 1235
2020
Q2
$44.2K Hold
475
0.02% 328
2020
Q1
$34.9K Buy
475
+134
+39% +$11.6K 0.02% 340
2019
Q4
$28.7K Hold
341
0.01% 468
2019
Q3
$28.7K Buy
341
+230
+207% +$17.4K 0.02% 467
2019
Q2
$7.26K Sell
111
-89
-45% -$5.13K ﹤0.01% 846
2019
Q1
$11.8K Buy
+200
New +$11.9K 0.01% 749

Other funds holding MEDP

Sutton Wealth Advisors's MEDP Position: Q1 2023 in Review

Sutton Wealth Advisors sold out of Medpace (MEDP) in Q1 2023, closing a stake of 5 shares — an estimated $1.06K sold.

Sutton Wealth Advisors first reported a position in MEDP in Q1 2019 and held it in 10 quarters. The position peaked at $44.2K in Q2 2020. 416 funds tracked by Wall St. Rank hold MEDP as of Q1 2023.

  • Sutton Wealth Advisors reported no remaining Medpace position as of Q1 2023 after selling out during the quarter.
  • Sutton Wealth Advisors sold 5 Medpace shares in Q1 2023, an estimated $1.06K.
  • Sutton Wealth Advisors first reported a position in Medpace in Q1 2019 and held it in 10 quarters.
  • Sutton Wealth Advisors's Medpace position peaked at $44.2K in Q2 2020.
  • 416 funds tracked by Wall St. Rank held Medpace as of Q1 2023.

Based on Sutton Wealth Advisors's 13F filing for Q1 2023, filed 7 Nov 2023.